Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2009-02-09Clinical Trial Update: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer [Phase 3]
This update covers a Phase 3 clinical trial evaluating combination chemotherapy plus radiation therapy in patients with small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2009-01-27Clinical Trial Update: Doxil Topotecan Doublet Cancer Study [Phase 1]
A Phase 1 trial evaluating a Doxil (liposomal doxorubicin) and topotecan doublet across multiple cancers has completed.
-
CLINICAL_TRIALS trial_result · 2009-01-21Clinical Trial Update: Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating picoplatin as second-line therapy for small cell lung cancer has completed. The sponsor is Poniard Pharmaceutical…
-
CLINICAL_TRIALS trial_result · 2008-12-23Clinical Trial Update: Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide [Phase 2, Phase 3]
This clinical trial update reports the evaluation of overall survival for Meclinertant versus placebo after first-line cisplatin plus etopos…
-
FDA approval · 2008-09-05FDA Approved: HYCAMTIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Hycamtin (topotecan) submitted by Sandoz Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-09-03Clinical Trial Update: Feasibility Study of CDDP + CPT-11 + PSK for Extensive-Stage Disease (ED) Small Cell Lung Cancer [Phase 2]
This is a Phase 2 feasibility trial evaluating cisplatin (CDDP), irinotecan (CPT-11), and polysaccharide-K (PSK) for extensive-stage small c…
-
CLINICAL_TRIALS trial_result · 2008-08-08Clinical Trial Update: A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa [Phase 3]
A Phase 3 trial in previously untreated extensive-stage small cell lung cancer compares platinum plus etoposide chemotherapy with or without…
-
CLINICAL_TRIALS trial_result · 2008-07-24Clinical Trial Update: Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer [Phase 1]
A phase 1 study evaluating the safety of combining Imatinib Mesylate with chemotherapy in patients with extensive-stage small cell lung canc…
-
CLINICAL_TRIALS research · 2008-07-24Clinical Trial Update: BBR 3464 in Treating Patients With Metastatic Small Cell Lung Cancer That Has Not Responded to Previous Treatment [Phase 2]
An update on a Phase 2 clinical trial evaluating BBR 3464 in patients with metastatic small cell lung cancer that has not responded to prior…
-
CLINICAL_TRIALS trial_result · 2008-06-12Clinical Trial Update: A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer [Phase 2]
Phase 2 study of gefitinib (IRESSA) in relapsed and refractory small cell lung cancer has completed.
-
CLINICAL_TRIALS research · 2008-03-12Clinical Trial Update: Topotecan for Irinotecan-Refractory SCLC [Phase 2]
A Phase 2 clinical trial update investigating the use of topotecan for irinotecan-refractory small cell lung cancer.
-
FDA approval · 2007-10-11FDA Approved: HYCAMTIN — Original Application (Sandoz Inc)
FDA approved HYCAMTIN (topotecan) from Sandoz as the original application; the initial indications included treatment of relapsed small cell…
-
CLINICAL_TRIALS withdrawal · 2007-04-05Clinical Trial Update: Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial of oxaliplatin plus CPT-11 (irinotecan) for extensive-stage small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned [Phase 2]
A Phase 2 study of pemetrexed in small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2006-07-20Clinical Trial Update: ALIMTA(Pemetrexed)/Cisplatin and ALIMTA(Pemetrexed)/Carboplatin in Extensive Stage Small Cell Lung Cancer. [Phase 2]
A Phase 2 clinical trial evaluating pemetrexed (ALIMTA) with cisplatin or with carboplatin in extensive-stage small cell lung cancer; status…